Heart Test Laboratories Inc.
HSCS
Get informed when a big investor buys or sells
+ FollowMarket Cap$11.23M
Close$
$-2.03
143.9% downside
Current Fair Value
143.9% downsideOvervalued by 143.9% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $11.23 Million |
|---|---|
| Enterprise Value | $-14,672,077.00 |
| Dividend Yield | $- (-) |
| Earnings per Share | $-3.48 |
| Beta | 1.86 |
| Outstanding Shares | 3,668,945 |
Return
| Return on Equity | 101443.94% |
|---|---|
| Return on Assets | -55190.03% |
| Return on Invested Capital | 99218.27% |
Valuation & Multiples
| P/E Ratio | -1.63 |
|---|---|
| PEG | 1.63 |
| Price to Sales | - |
| Price to Book Ratio | -4.63 |
| Enterprise Value to Revenue | -7.7 |
| Enterprise Value to EBIT | 0.01 |
| Enterprise Value to Net Income | 0 |
| Total Debt to Enterprise | -0.27 |
| Debt to Equity | -1.97 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
September 14, 2026
EPS Estimate
$-0.72
Average shareholder expectationRevenue Estimate
$100,000
Average shareholder expectationNext Earnings Call
Expected Date
December 10, 2026
EPS Estimate
$-0.65
Average shareholder expectationRevenue Estimate
$100,000
Average shareholder expectationInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data